CLEAR-ER was a multicenter , double-blind , randomized study ; rt-PA-eligible AIS patients were randomized to .6 mg/kg rt-PA plus eptifibatide ( 135 mcg/kg bolus and .75 mcg/kg/min two-hour infusion ) versus standard rt-PA ( .9 mg/kg ) .